INVESTIGACIÓN

 
  • Grupos de Investigación
  • Unidades de Investigación
  • Memoria Cientifíca
  • Publicaciones
espacio

 

PUBLICACIONES

 

 

spacerTrabajos Publicados por Miguel Angel Zaballos Sánchez
spacer
  1. Zaballos, M.A.; Acuña-Ruiz, A.; Morante, M.; Riesco-Eizaguirre, G.; Crespo, P.; Santisteban, P. "Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer.". Cell Mol Life Sci. 79(9): 504. (2022). (PMID: 36056964).
    spacer

  2. Ramirez-Moya, J.; Wert-Lamas, L.; Acuña-Ruiz, A.; Zaballos, M.A.; Santisteban, P. "In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice.". J Vis Exp. (150): . (2019). (PMID: 31498304).
    spacer

  3. Zaballos, M.A.; Acuña-Ruiz, A.; Morante, M.; Crespo, P.; Santisteban, P. "Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer.". Endocr. Relat. Cancer. 26(6): R319-R344. (2019). (PMID: 30978703).
    spacer

  4. Moya, C.M.; Zaballos, M.A.; Garzón, L.; Luna, C.; Simón, R.; Yaffe, M.B.; Gallego, E.; Santisteban, P.; Moreno, J.C. "TAZ/WWTR1 Mediates the Pulmonary Effects of NKX2-1 Mutations in Brain-Lung-Thyroid Syndrome.". J. Clin. Endocrinol. Metab.. 103(3): 839-852. (2018). (PMID: 29294041).
    spacer

  5. Zaballos, M.A.; Santisteban, P. "Key signaling pathways in thyroid cancer.". J. Endocrinol.. 235(2): R43-R61. (2017). (PMID: 28838947).
    spacer

  6. Sastre-Perona, A.; Riesco-Eizaguirre, G.; Zaballos, M.A.; Santisteban, P. "β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation.". Oncotarget. 7(31): 49435-49449. (2016). (PMID: 27384483).
    spacer

  7. Zaballos, M.A.; Cantero, W.; Azpiazu, N. "The TALE transcription factor homothorax functions to assemble heterochromatin during Drosophila embryogenesis.". PLoS One. 10(3): e0120662. (2015). (PMID: 25794008).
    spacer

  8. Zaballos, M.A.; Santisteban, P. "FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.". Mol. Endocrinol.. 27(1): 50-62. (2013). (PMID: 23160481).
    spacer

  9. Chocarro-Calvo, A.; Zaballos, M.A.; Santisteban, P.; García-Jiménez, C. "DARPP-32 is required for MAPK/ERK signaling in thyroid cells.". Mol. Endocrinol.. 26(3): 471-480. (2012). (PMID: 22301787).
    spacer

  10. Zaballos, M.A.; Garcia, B.; Santisteban, P. "Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.". Mol. Endocrinol.. 22(5): 1183-1199. (2008). (PMID: 18202153).
    spacer

  11. García-Jiménez, C.; Zaballos, M.A.; Santisteban, P. "DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation.". Mol. Endocrinol.. 19(12): 3060-3072. (2005). (PMID: 16020482).
    spacer

 

 

 

 

 

Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401
Email:Info